Things I'd like more life for — yolopeptide

MOTS-c and physical decline

The old mice could do more. In a 2021 MOTS-c experiment, mice aged 22 to 23.5 months showed improvements in treadmill running capacity, grip strength and gait. The researchers tested physical performance; they did not measure whether those mice lived longer.

Old animals doing a little more: I could spend some time with that possibility. Walking, gripping, getting somewhere: ordinary tasks give a longevity claim some substance. Being able to do things deserves a place near the beginning of the conversation.

The experiment used mice. Human evidence for administered MOTS-c has yet to establish that benefit, and the review of its stress, metabolism and ageing research leaves a considerable distance between those animal tests and a treatment for people.

Daily movement

YOLO usually sounds like permission to take a chance. I hear something more practical in it: attention to the life already happening. A table-tennis rally will do; so will carrying a bag or walking out to meet someone. These are examples of the capacity I value, rather than effects established for either peptide in people.

The label “anti-ageing” gets on my nerves because it covers such different findings. It can cover a longer-lived cell, an animal that runs farther or a lower mortality rate, leaving the reader to imagine the rest. Give me a convincing human test of everyday movement and the grand adjective can retire.

Epitalon

Epitalon, also called Epithalon or AEDG, starts with a different kind of possibility. Its telomere result in cultured human cells concerns the protective ends of chromosomes. The survival experiment in female SHR mice concerns whole animals: maximum lifespan increased 12.3%, while mean lifespan was unchanged.

That is worth investigating. It also leaves my table-tennis question unanswered. A cell's continued division and an animal's survival describe pieces of ageing; the ability to spend a day as one wishes requires a human result of its own. The Epitalon page follows the cell, animal and human-extract findings without giving them credit for one another.

Further pages

MOTS-c and muscle follows the treadmill result into energy sensing, muscle wasting and the human blood-marker study. Healthspan versus lifespan stays with the question of how the years are spent.

For a direct comparison, the Epitalon vs MOTS-c table puts their actual subjects and outcomes alongside each other. The questions page covers safety, research status and the requests for dosing that the human evidence cannot answer.